Aurélien Rizk is the CSO and co-founder of InterAx Biotech, contributing to the company's focus on drug discovery. As a scientist and entrepreneur, he has a background in developing mathematical modeling, numerical simulations, and AI methods for drug discovery. InterAx Biotech, a spin-out of ETH Zurich and the Paul Scherrer Institute, specializes in high-throughput biochemical screening of compou...